A randomized, double-blind, comparison of 3 doses of emtricitabine (FTC) in patients with chronic hepatitis B (CHB) given 48 weeks of treatment (FTCB-102): Nancy Leung, Prince of Wales Hosp and Chinese Univ of Hong Kong; Shatin Hong Kong; Robert G Gish, CA Pacific Medical Ctr, San Francisco, CA; Chia Wang, Larry Corey, Univ of Washington, Seattle, WA; Stephen Sacks, Viridae Clin Sciences and Univ of BC, Vancouver, BC Canada; Michael Fried, Univ of North Carolina, Chapel Hill, NC; Teresa Wright, Veterans Medical Ctr, San Francisco, CA; Trinh Huy, CA Pacific Medical Ctr, San Francisco, CA; Francis Chan, Prince of Wales Hosp and Chinese Univ of Hong Kong, Shatin Hong Kong; Franck S Rousseau, Triangle Pharmaceuticals, Durham, NC

• Book ID: 118689089
• Publisher: John Wiley and Sons
• Year: 2001
• Tongue: English
• Weight: 228 KB
• Volume: 34
• Category: Article
• ISSN: 0270-9139
• DOI: 10.1053/s0270-9139(00)82840-2